Incyte (INCY) upgraded to Buy on pipeline progress, improving EPS and Monjuvi Phase 3 data; Vega Therapeutics deal boosts ...

Afya (AFYA) stock analysis: strong finances but rising competition, ENAMED fallout, and regulatory risks weaken earnings ...

Disney (DIS) stock analysis: why consumer stress, inflation, and slow revenue growth keep a Hold rating despite attractive ...

StealthGas (GASS) looks undervalued: 50% discount to book, no debt, strong liquidity. Current macro tailwinds are driving ...

CVS Health posted other positive signs of growth, such as improved retail pharmacy market share. Read why CVS stock is a Buy.

The Nationwide Loomis Short Term Bond Fund slightly outperformed its benchmark in Q1 2026. Read the full analysis for more ...

The blockbuster US jobs report released Friday showed the nonfarm payroll increased by 172,000 in May, almost double market ...

Paramount Skydance's streaming momentum is accelerating, with Paramount+ reaching 79.6 million subscribers. Read why PSKY ...

BlackRock's New Jersey Municipal Bond Fund posted slight losses in Q1 2026 due to weakness in education and school sectors.

ZIM shipping is in acquisition talks as container rates surge, boosting earnings. ZIM's strong financial position underpins ...

John Hancock 2065 Lifetime Portfolio underperformed its benchmark due to equity overweighting and Middle East conflict ...

The Invesco High Yield Fund saw Q1 negative returns as geopolitical tensions and inflation concerns drove a market selloff.